Scientific article
Letter
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis
ContributorsÖzdemir, B C; Latifyan, S; Perreau, M; Fenwick, C; Alberio, L; Waeber, G; Spertini, F; de Leval, L; Michielin, Olivier
Published inAnnals of oncology, vol. 31, no. 12, p. 1775-1778
Publication date2020-12
First online date2020-08-25
Keywords
- Antibodies, Monoclonal, Humanized / adverse effects
- Cytokines
- Humans
- Immune Checkpoint Inhibitors
- Lymphohistiocytosis, Hemophagocytic / drug therapy
Affiliation entities Not a UNIGE publication
Citation (ISO format)
ÖZDEMIR, B C et al. Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis. In: Annals of oncology, 2020, vol. 31, n° 12, p. 1775–1778. doi: 10.1016/j.annonc.2020.08.2101
Main files (1)
Article (Published version)
Identifiers
- PID : unige:191529
- DOI : 10.1016/j.annonc.2020.08.2101
- PMID : 32858151
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0923753420421568
Journal ISSN0923-7534
